Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Left-ventricular assist devices (LVADs) improve outcomes in end-stage heart failure patients. Two centrifugal-flow LVAD systems are currently approved, HeartMate 3 (HM3) and Medtronic/Heartware HVAD (HVAD). Clinical findings suggest differences in thrombogenicity between both systems. We compared ma...

Full description

Bibliographic Details
Main Authors: Maximilian Tscharre, Franziska Wittmann, Daniela Kitzmantl, Silvia Lee, Beate Eichelberger, Patricia P. Wadowski, Günther Laufer, Dominik Wiedemann, Birgit Forstner-Bergauer, Cihan Ay, Simon Panzer, Daniel Zimpfer, Thomas Gremmel
Format: Article
Language:English
Published: Taylor & Francis Group 2022-02-01
Series:Platelets
Subjects:
lvad
heartmate 3
hvad
platelet activation
platelet aggregation
Online Access:http://dx.doi.org/10.1080/09537104.2021.1881950

Internet

http://dx.doi.org/10.1080/09537104.2021.1881950

Similar Items